BioCentury
ARTICLE | Company News

Haemostatix hematology news

November 12, 2012 8:00 AM UTC

Haemostatix received a £1.4 million ($2.2 million) translation award from Wellcome Trust to continue development of its hemostat technology and advance PeproStat into clinical trials. Haemostatix pla...